Mathew Blackman
Stock Analyst at Stifel
(3.17)
# 1,347
Out of 4,996 analysts
61
Total ratings
53.49%
Success rate
12.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $8.22 | -14.84% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $12.00 | +158.33% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $253.37 | +25.51% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $21.55 | +16.01% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $19.53 | +28.01% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $318.00 | -7.86% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $55.70 | +68.76% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $14.29 | +67.95% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.44 | +108.33% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $67.10 | +49.03% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $15.02 | +6.52% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $8.89 | +23.73% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $8.22
Upside: -14.84%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $12.00
Upside: +158.33%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $253.37
Upside: +25.51%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $21.55
Upside: +16.01%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $19.53
Upside: +28.01%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $318.00
Upside: -7.86%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $55.70
Upside: +68.76%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $14.29
Upside: +67.95%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.44
Upside: +108.33%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $67.10
Upside: +49.03%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $15.02
Upside: +6.52%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $8.89
Upside: +23.73%